Form 8-K - Current report:
SEC Accession No. 0001823239-26-000049
Filing Date
2026-06-03
Accepted
2026-06-03 08:31:58
Documents
13
Period of Report
2026-06-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20260602.htm   iXBRL 8-K 41036
2 EX-10.1 newcreditagreement.htm EX-10.1 2350038
3 EX-99.1 finalmaravai-debtrefinance.htm EX-99.1 7736
  Complete submission text file 0001823239-26-000049.txt   2890534

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20260602.xsd EX-101.SCH 1782
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20260602_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20260602_pre.xml EX-101.PRE 13046
16 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20260602_htm.xml XML 2833
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 261059028
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)